PANACEABIO.BOPANACEABIO.BOBSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank13
3Y CAGR-27.7%
5Y CAGR-19.7%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-27.7%/yr
vs -28.0%/yr prior
5Y CAGR
-19.7%/yr
Recent deceleration
Acceleration
+0.3pp
Accelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM4.67%-15.1%
20255.50%-26.9%
20247.53%-39.0%
202312.34%-95.1%
2022253.93%+1712.8%
202114.01%+66.8%
20208.40%-81.7%
201945.86%+185.5%
201816.06%-25.3%
201721.50%-